Project Grant P30GM159561
Award Date
8/1/25
Completion Date
5/31/30
Dollars Obligated
$1.1M
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Little Rock, AR 72205, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $470,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Institute For Cancer Research, a non-profit subsidiary of Temple University, for a 5-year research project starting on September 17, 2024. The goal of the project is to characterize the molecular-level interactions and coordination events coupling the repair of oxidative DNA damage and gene enhancement at G-quadruplex promoter regions in...
The National Institute of General Medical Sciences (NIGMS) awarded a $389,211 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Massachusetts (UMass) Amherst. The grant, which runs from July 2024 to June 2029, will fund research to investigate the biophysical and molecular mechanisms underlying a novel process of "meso-scale gap closure" in tissues undergoing epithelial-mesenchymal transition. The research aims to...
The National Institute of General Medical Sciences (NIGMS) awarded a $268,734 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to the University of Chicago for the "SHE (SUMMER HEALTHCARE EXPERIENCE) IN ONCOLOGY" program. This virtual, multi-institutional STEM enrichment program aims to increase participation of women from underrepresented backgrounds in the cancer biomedical workforce. The program provides high school students with hands-on research experience,...
This $420,335 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research focused on understanding the role of lytic viral gene expression in the development and maintenance of oncogenic gammaherpesvirus-associated cancers. The University of Arkansas for Medical Sciences (UAMS) is leading this 2-year research project to test the hypothesis that lytic gene expression is...
The National Institute of General Medical Sciences (NIGMS) awarded a $384,896 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Missouri System. The award will fund research to engineer peptide-based biomodulatory materials that can serve as translational platform technologies for various biomedical applications. Specific objectives include using computational and experimental techniques to develop design rules for micellar...
This $2,463,036 five-year Project Grant was awarded on June 10, 2025 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training federal grant program (CFDA 93.859). The grant supports the establishment of the Center for Genomic Regulation (CGR) at the Oklahoma Medical Research Foundation (OMRF) to build a focused research community that performs collaborative research and effective training in the areas of chromatin, DNA modifications,...
This Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, provides $688,500.00 in funding to the University of Arkansas for Medical Sciences (UAMS) for a 3-year period from November 15, 2024 to November 14, 2027. The grant supports research to investigate "Mechanisms of Combinatorial Therapy to Enhance Anti-PD-1 Immune Checkpoint Inhibition for Ovarian Cancer". As a leading academic...
The National Institute of General Medical Sciences (NIGMS) awarded a $754,625 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to the University of Florida. The grant, effective September 1, 2024 through June 30, 2029, will fund research to understand the interaction between ultra-small nanoparticles (USNPs) and myeloid cells, such as inflammatory monocytes, and how myeloid cell trafficking can be leveraged to improve the targeting of...
The National Institute of General Medical Sciences (NIGMS) awarded a $440,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research in New York. The 5-year grant, awarded on February 3, 2025, supports advanced research to decode the ubiquitin and autophagy signaling networks, which are essential cellular processes involved in proteome homeostasis. The research program combines expertise in quantitative mass spectrometry,...
The National Institute of General Medical Sciences (NIGMS) has awarded a $294,147 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to the University of Kansas Center for Research Inc. The 5-year grant, effective June 1, 2025, will support the development of advanced computational modeling approaches to characterize macromolecular interactions within living cells. The project aims to bridge classical docking and biomolecular simulation methods to enable...